The National Institutes of Health, the National Institute of Dental and Craniofacial Research, the Phileona Foundation, and the Sjögren’s Syndrome Foundation helped fund the SICCA and OMRF cohort studies on which the criteria were based. Dr. Shiboski and Dr. Seror had no disclosures. Dr. Baer reported having been a consultant for Bristol-Myers Squibb and Glenmark Pharmaceuticals.
* Correction, 11/17/15: Dr. Shiboski's gender was previously misstated.